"the reality is the entire company is now worth significantly less..."
KSD, you just indicated either a lack of knowledge of basic valuation, or are being deliberately misleading (you choose).
Your statement refers to the firm's market capitalization. Although important, market cap isn't the firm's "worth". Instead, a company's "worth" is usually considered its break-apart value, typically its net tangible asset value (book value).
DNA's book value was 57 cents per share in June 2016, and is estimated to be worth 61 cents in 2017. In short, the market (as usual) is swinging its pendulum far from the firm's worth.
DNA Price at posting:
35.0¢ Sentiment: None Disclosure: Held
